Results 151 to 160 of about 61,456 (351)
Az infliximab kezelés szerepe gyulladásos bélbetegségekben [PDF]
A gyulladásos bélbetegségek kezelése máig is megoldatlan kérdés. A gyulladásos cascad részvevőire ható un. „biológiai szerek” alapvetően új kezelési lehetőséget biztosítanak.
Lakatos, Péter László, Papp, János
core
En este segundo artículo sobre la patología del intestino delgado se aborda la patología de carácter local o regional, entre la que se incluyen la enfermedad de Crohn y los tumores. Consideramos como patología de carácter local o regional en el intestino
Luis H. Ros Mendoza +4 more
doaj
Arachidonic acid concentrations in patients with Crohn disease
Karen C. McCowen +2 more
openalex +1 more source
Bone biochemistry and bone metabolism in patients with Crohns disease
Sarah Bartram +3 more
openalex +1 more source
Mendelian randomization (MR) studies were conducted using the inverse‐variance weighted (IVW) method, MR‐Egger and weighted median on juvenile myoclonic epilepsy (JME), and systemic lupus erythematosus (SLE) data from the Integrative Epidemiology Unit (IEU) Open genome‐wide association study (GWAS) database and the International League Against Epilepsy
Sirui Chen +10 more
wiley +1 more source
Prognosis and prognostic factors in inflammatory bowel disease
The chance of normal survival for patients with inflammatory bowel disease is generally good. There may be a small excess mortality for those with Crohn′s disease; however recent studies do not confirm this trend. For those with ulcerative colitis,
Thompson Nicholas +2 more
doaj
Lipid peroxidation and plasma antioxidant micronutrients in Crohn disease
Barbara Wendland +7 more
openalex +1 more source
Abstract Objective In the present study, a bidirectional two‐sample Mendelian randomization approach was utilized to explore potential causal relationships between mitochondrial DNA copy number (mtDNA‐CN) and ovary‐related reproductive disorders (ORRDs), including ovarian dysfunction, ovarian cyst, polycystic ovary syndrome (PCOS), premature ovarian ...
Ke Peng +4 more
wiley +1 more source

